Logo image of BUJA

BUKIT JALIL GLOBAL ACQUISITI (BUJA) Stock Fundamental Analysis

NASDAQ:BUJA - Nasdaq - KYG1676M1050 - Common Stock - Currency: USD

11.39  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BUJA. BUJA was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BUJA have multiple concerns. BUJA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BUJA was profitable.
In the past year BUJA has reported a negative cash flow from operations.
BUJA Yearly Net Income VS EBIT VS OCF VS FCFBUJA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 500K 1M

1.2 Ratios

Industry RankSector Rank
ROA 5.57%
ROE 6.03%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BUJA Yearly ROA, ROE, ROICBUJA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 50 100 150

1.3 Margins

BUJA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BUJA Yearly Profit, Operating, Gross MarginsBUJA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

BUJA has more shares outstanding than it did 1 year ago.
There is no outstanding debt for BUJA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BUJA Yearly Shares OutstandingBUJA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M
BUJA Yearly Total Debt VS Total AssetsBUJA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M

2.2 Solvency

BUJA has an Altman-Z score of 13.34. This indicates that BUJA is financially healthy and has little risk of bankruptcy at the moment.
BUJA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 13.34
ROIC/WACCN/A
WACCN/A
BUJA Yearly LT Debt VS Equity VS FCFBUJA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 10M 20M 30M 40M 50M

2.3 Liquidity

BUJA has a Current Ratio of 0.19. This is a bad value and indicates that BUJA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.19 indicates that BUJA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
BUJA Yearly Current Assets VS Current LiabilitesBUJA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 100K 200K 300K

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BUJA Yearly Revenue VS EstimatesBUJA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
BUJA Yearly EPS VS EstimatesBUJA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 49.52, which means the current valuation is very expensive for BUJA.
BUJA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 49.52
Fwd PE N/A
BUJA Price Earnings VS Forward Price EarningsBUJA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BUJA Per share dataBUJA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BUJA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BUKIT JALIL GLOBAL ACQUISITI

NASDAQ:BUJA (3/7/2025, 8:08:56 PM)

11.39

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners58.45%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner Change0%
Market Cap56.27M
AnalystsN/A
Price TargetN/A
Short Float %0.06%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 49.52
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB 1.88
EV/EBITDA N/A
EPS(TTM)0.23
EY2.02%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0
BVpS6.06
TBVpS6.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.57%
ROE 6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 13.34
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2433.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1708.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1708.5%
OCF growth 3YN/A
OCF growth 5YN/A